Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis
NCT03342807 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 220
Last updated 2017-11-17
Summary
To investigate an economical and effective way to reduce the level of serum triglyceride in patients with hypertriglyceridemia-induced acute pancreatitis.
Conditions
- Pancreatitis, Acute
- Hypertriglyceridemia
Interventions
- DRUG
-
Insulin infusion for subjects in Group Insulin.
- DEVICE
-
Aphesis
Aphesis for subjects in Group Aphesis.
Sponsors & Collaborators
-
First Hospitals affiliated to the China PLA General Hospital
collaborator OTHER_GOV -
Nanjing General Hospital
collaborator UNKNOWN -
Fujian Provincial Hospital Emergency Center
collaborator UNKNOWN -
First Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
Jinhua Central Hospital
collaborator OTHER -
Guangdong Provincial Hospital of Traditional Chinese Medicine
collaborator OTHER -
First Affiliated Hospital of Kunming Medical University
collaborator OTHER -
Tianjin Medical University General Hospital
collaborator OTHER -
The First Hospital of Hebei Medical College
collaborator UNKNOWN -
The First Affiliated Hospital with Nanjing Medical University
collaborator OTHER -
Shenzhen Baoan District People 's Hospital
collaborator UNKNOWN -
The General Hospital of Shenyang Military
collaborator UNKNOWN -
Cangzhou Center Hospital
collaborator UNKNOWN -
Wuxi Third People 's Hospital
collaborator UNKNOWN -
General Hospital of Ningxia Medical University
collaborator OTHER -
Peking Union Medical College Hospital
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-30
- Primary Completion
- 2019-11-30
- Completion
- 2020-11-30
- FDA Drug
- Yes
- FDA Device
- Yes
More Related Trials
-
A Study on the Changes of Glucose Metabolism and Exocrine Function in Patients With Chronic Pancreatitis
NCT07314489 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Haemodynamic Effects of GLP-1 and Glucagon in Healthy Male Volunteers
NCT03835013 ·Status: COMPLETED ·Phase: NA
-
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
NCT06825182 ·Status: RECRUITING ·Phase: PHASE3
-
Acute Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon
NCT01155206 ·Status: COMPLETED ·Phase: PHASE4
-
Plasma Glucagon-like Peptide-1 Levels and In-hospital Complications in ST-segment Elevation Myocardial Infarction
NCT03314844 ·Status: COMPLETED
-
Characterizing the Incretin Effect of Amino Acids and Defining GLP-1 Role on Skeletal Muscle
NCT02370745 ·Status: COMPLETED ·Phase: NA
-
Study of Comparison the Treatment Effect Between Gastric Bypass and Exenatide in Type 2 Diabetes
NCT01435980 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase 1 Study of Potential Anti-Inflammatory Effects of Glucose Control During Acute Myocardial Infarction.
NCT00209144 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of Glucose Control, β Cell Function in Response to Short-term Insulin Pump Therapy in Type 2 Diabetes
NCT03509324 ·Status: COMPLETED ·Phase: PHASE4
-
Separate and Combined Extrapancreatic Effects of GIP and GLP-1
NCT06895408 ·Status: COMPLETED ·Phase: NA
-
Diabetes RElated to Acute Pancreatitis and Its Mechanisms
NCT05197920 ·Status: RECRUITING
-
Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM
NCT04965051 ·Status: UNKNOWN ·Phase: NA
-
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
NCT05264727 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"
NCT00881543 ·Status: COMPLETED ·Phase: NA
-
Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging
NCT02833415 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes
NCT00544206 ·Status: COMPLETED ·Phase: PHASE2
-
Plasma GLP1 and Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
NCT02846168 ·Status: UNKNOWN
-
Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin
NCT02984644 ·Status: COMPLETED ·Phase: PHASE3
-
NEW ONSET ENDOCRINE DYSFUNCTION AFTER ACUTE PANCREATITIS
NCT04513197 ·Status: UNKNOWN
-
Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
NCT02324842 ·Status: COMPLETED ·Phase: NA
-
Plasma Glucagon-like Peptide-1 Levels and Acute Myocardial Infarction
NCT03129594 ·Status: COMPLETED
-
Separate and Combined Extrapancreatic Effects of the Incretin Hormones
NCT05177653 ·Status: COMPLETED ·Phase: NA
-
An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
NCT02793154 ·Status: TERMINATED ·Phase: PHASE4
-
Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
NCT04135287 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy
NCT02129985 ·Status: UNKNOWN ·Phase: PHASE4